Skip to main content

Shaibu plots to succeed Obaseki in 2024 — Ebea

By
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-
Former deputy Speaker of the Edo State House of Assembly, Festus Ebea, called on the people of Edo Central Senatorial District to vote for the APC candidate in the forth coming governorship election.

 He said contrary to promises being made by Governor Godwin Obaseki, his deputy, Comrade Philip Shaibu, is surely having a plot to takes over from his boss in 2024.

He said voting for Pastor Osagie Ize-Iyamu was the best bet for Edo Central to have a shot at the governorship seat.

In a chat with Vanguard, Ebea alleged that if Obaseki wins his second term, he would hand over to Shaibu in their third year and then proceed to the Senate and pave the way for Shaibu to begin a fresh term in 2024.

Ebea said: “I remember in 2012 when we were celebrating the victory of Comrade Adams Oshiomhole’s second term re-election. We, as colleagues, we were just so joyous and out of excitement he (Shaibu) said after Comrade, the next person that will take over from him will certainly hand over to him.

“And when you see the events playing out, especially within the executive sphere of Edo State, you will find out that the relationship that now exists between the Governor and Deputy Governor, is not borne out of anything other than to respect the wish of Philip Shaibu."

He described Ebea’s comments on the 2024 governorship election as sickening and unacceptable.

Shaibu: “My destiny is in the hands of God and it is only God that can determine the future. I don’t know the next position that God is taking me.I am not like Ebea that brags on his ability. I brag on God’s ability, which is my driving force. He should speak about himself. He should not speak for me.”

Former Deputy Speaker of the Edo State House of Assembly, Festus Ebea, on Tuesday, called on the people of Edo Central Senatorial District to vote for All Progressives Congress, APC, and its candidate in the September 19 governorship election, saying contrary to promises being made by Governor Godwin Obaseki, his deputy, Comrade Philip Shaibu, is actually plotting to ensure he takes over from his boss in 2024.results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal, The Lancet, indicate no early safety concerns even as it induces strong immune responses in both parts of the immune system. According to the report, the vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days (antibodies are able to neutralise the virus so that it cannot infect cells when initially contracted).

Read more at: https://www.vanguardngr.com/2020/07/oxford-coronavirus-vaccine-produces-strong-immune-response-study/
Labels:

Comments

Post a Comment

Popular posts from this blog

EndSARS: Protesters In New York Want SARS Operatives Sacked

By
 Hundreds of young anti-SARS protesters on Sunday stormed the Nigeria House in New York demanding transparency in the disbandment of the police unit back home. The protesters said operatives of the Special Anti-Robbery Squad found wanting should be sacked and not redeployed. Among them was Stephen “Papi” Ojo, the artist, model, and choreographer who stole the show as the ‘blue-guy’ in Beyoncé’s “Already” music video. The protest started shortly after the Inspector-General of Police, Mohammed Adamu, announced the dissolution of the Federal Special Anti-Robbery Squad. Adamu also announced plans for a new arrangement to address anticipated policing gaps following the disbandment, and the constitution of an investigative team to probe the alleged cases of rights violations, among others. But the protesters, who bore placards with different inscriptions including, “We no want audio ban”, said they were not buying it. They argued that previous commitments announced by the force to change...
Post a Comment
Read more

How Soldiers Police Fled Abandoning Delta Community Residents During Bloody Robbery Incident

By
There was pandemonium in Issele-Uku branch, headquarters of Aniocha North Local Government Area of Delta state on Tuesday as some armed robbers attacked a branch of United Bank for Africa (UBA) in the town. A eyewitness said the robbers gained entrance into the bank after using explosives suspected to be dynamite to blast the bullet-proof door.  According to the eyewitness, the robbers spent over one hour on the operation. He disclosed that no fewer than four persons were killed in the robbery attack. The eyewitness said security operatives around the area refused to show up until the robbers had left. “This attack is a reoccurring one in the community. Yesterday, they robbed for an hour and the police didn't show up, neither did the army nor the community vigilantes until they left, that was when they showed up as usual. “I counted about four bodies, the police station is about a minute drive from the scene of the robbery, while the NYSC (National Youth Service Corps) orientation ...
1 comment
Read more

Biden Announces Purchase Of 200M Vaccine Doses

By
  President Joe Biden announced a series of measures on Tuesday aimed at ramping up coronavirus vaccine allocation and distribution, including the purchase of 200 million more vaccine doses and increased distribution to states by millions of doses next week. With those additional doses, Biden said there would be enough to fully vaccinate 300 million Americans -- nearly the entire US population -- by the end of summer or early fall. He described efforts to combat Covid-19 as a "wartime undertaking." We now have a national strategy to beat Covid-19. It's comprehensive. It's based on science, not politics. It's based on truth, not denial, and it is detailed," he said. As part of the new efforts announced Tuesday, the US will buy 100 million more doses from Pfizer/BioNTech and 100 million more from Moderna -- the two-dose vaccines that have been granted emergency use authorization by the US Food and Drug Administration. Pfizer and Moderna are working to step up p...
Post a Comment
Read more